Global Rice Seed Treatment Market to Reach $527.6 Million by 2027
Amid the COVID-19 crisis, the global market for Rice Seed Treatment estimated at US$323.4 Million in the year 2020, is projected to reach a revised size of US$527.6 Million by 2027, growing at a CAGR of 7.2% over the period 2020-2027.
The U.S. Market is Estimated at $87.4 Million, While China is Forecast to Grow at 11% CAGR
The Rice Seed Treatment market in the U.S. is estimated at US$87.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$116.7 Million by the year 2027 trailing a CAGR of 11% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.9% and 6.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.We bring years of research experience to this 6th edition of our report. The 138-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.Competitors identified in this market include, among others,
- ADAMA Agricultural Solutions Ltd.
- Advanced Biological Marketing
- BASF SE
- Bayer CropScience AG
- BioWorks, Inc.
- Croda Crop Care
- Novozymes A/S
- Nufarm Limited
- Plant Health Care plc
- Syngenta AG
- Valent U.S.A Corporation
- Verdesian Life Sciences